Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Esperoct for adolescents and adults with hemophilia A

June 21, 2019

Phase II proof-of-concept study of REGN-3500 in asthma meets primary endpoint

June 21, 2019

PAOPA displays varied antiparkinsonian activity in vivo

June 21, 2019

Orion's OB-002 equivalent to anti-PD-1 antibody in preclinical colorectal cancer model

June 21, 2019

Pancreatic cancer biomarker turns out to be disease driver

June 21, 2019

Distal motor neuropathy found associated with mutations in GBF1 gene

June 21, 2019

Chinese PLA General Hospital patents compositions comprising bacillus Oscillibacter valericigenes

June 21, 2019

Bristol-Myers Squibb, Allied-Bristol Life Sciences patent EPRS inhibitors

June 21, 2019

New creatine prodrugs disclosed by Ultragenyx Pharmaceutical

June 21, 2019

MYBPC1 gene mutations tied to tremor-associated myopathy

June 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...